MORPOSYS AND ROCHE EXPAND THERAPEUTIC ANTIBODY PARTNERSHIP
MorphoSys AG and Roche today announced a collaboration to develop new therapeutic
antibodies in oncology. Expanding on a September 2000 relationship in Alzheimer's
disease, Roche will elect new target molecules against which MorphoSys will
generate antibodies using its proprietary HuCAL GOLD technology.